Schwab Charles CORP Form 4 insider transactions

Jonathan Beatty, a managing director at Charles Schwab, exercised stock options and sold shares on November 25, 2024, according to a recent SEC filing.

Nigel J. Murtagh, Chief Risk Officer of Charles Schwab, sold 12,739 shares of common stock at an average price of $81.1659 on November 22, 2024.

Director Christopher Dodds of Charles Schwab exercised stock options and sold shares on November 18, 2024, according to a recent SEC filing.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold a total of 9,000 shares of common stock on November 15, 2024, under a pre-arranged trading plan.

Director Stephen A. Ellis of Charles Schwab Corp. reported the acquisition of shares through a dividend reinvestment and a transfer of shares to a trust.

Jonathan Beatty, a Managing Director at Charles Schwab, exercised stock options and sold shares, according to a recent SEC filing.

Charles Schwab director Charles A. Ruffel sold 2,998 shares of common stock at an average price of $78.6454 on November 13, 2024.

Jonathan Beatty, a Managing Director at Charles Schwab, exercised stock options and sold shares under a pre-arranged trading plan.

Paul Woolway, MD, Chief Banking Officer of Charles Schwab Corp, reports a transaction involving common stock, including a gift and holdings through a trust and ESPP.

Richard A. Wurster, a President at Charles Schwab Corp, reported the acquisition and disposal of company stock, including shares withheld for taxes upon settlement of restricted stock units.

Charles R. Schwab, Co-Chairman of Charles Schwab Corp, recently sold 17,225 shares of common stock at an average price of $70.9047.

Director Carolyn Schwab-Pomerantz sold shares of Charles Schwab Corp on October 17, 2024, according to a Form 4 filing with the SEC.

Charles Schwab, Co-Chairman of Charles Schwab Corp, exercised stock options and transferred the resulting shares to a living trust, while also selling shares on the open market.

Director Stephen A. Ellis acquired 2,145 nonqualified stock options in Charles Schwab Corp. on October 1, 2024, under the Directors' Deferred Compensation Plan II.

Charles A. Ruffel, a director of Charles Schwab Corp, acquired stock options as part of the Directors' Deferred Compensation Plan II.

Frank Herringer, a director at Schwab, acquired 2,621 nonqualified stock options on October 1, 2024, in lieu of cash compensation under the Directors' Compensation Plan II.

Director Bharat Masrani acquired 470 Restricted Stock Units (RSUs) of Schwab (SCHW) on October 1, 2024, under the Directors' Deferred Compensation Plan II.

Director Marianne Catherine Brown acquired 587 restricted stock units (RSUs) of The Charles Schwab Corporation on October 1, 2024, through the Directors' Deferred Compensation Plan II.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold shares of common stock on September 17, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, reported the sale of common stock on August 15 and 16, 2024, according to a Form 4 filing with the SEC.

Paul Woolway, MD and Chief Banking Officer of Schwab, reports a sale of common stock and updates on beneficial ownership, including holdings in trust and ESPP.

Charles Schwab, Co-Chairman of Charles Schwab Corp, exercised stock options and transferred the resulting shares to a living trust.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) common stock on July 19, 2024, under a pre-arranged 10b5-1 trading plan.

Walter Bettinger, Co-Chairman and CEO of Schwab, recently purchased 25,000 shares of Schwab stock at a price of $66.26 per share.

Richard Wurster, President of Charles Schwab Corp, recently purchased 10,000 shares of the company's common stock at an average price of $62.0454.

Jonathan Beatty, MD, Head of Advisor Services at Charles Schwab Corp, exercised stock options and sold shares under a pre-arranged trading plan.

Charles A. Ruffel, a director at Charles Schwab Corp, acquired 1,632 nonqualified stock options on July 1, 2024, in lieu of cash compensation.

Director Bharat Masrani acquired 409 Restricted Stock Units (RSUs) in Schwab Charles Corp on July 1, 2024, through the Directors' Deferred Compensation Plan II.

Director Marianne Catherine Brown acquired 511 Restricted Stock Units (RSUs) in Charles Schwab Corp on July 1, 2024, under the Directors' Deferred Compensation Plan II.

Stephen A. Ellis, a director of Charles Schwab Corp, acquired 1,836 nonqualified stock options on July 1, 2024, in lieu of cash compensation.